Benitec Biopharma Inc. (BNTC) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
Address
3940 Trust Way
Hayward, CA 94545
United States of America (the)
Phone
510 780 0819
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
June 24, 2014
| Name | Title | Pay | Year Born |
| Jerel A. Banks | Executive Chairman & Chief Executive Officer | 1.07M | 1976 |
| Michael Graham | Head of Discovery & Founding Scientist | 135,535 | N/A |
| Megan Joan Boston | CFO & Secretary | 870,813 | 1973 |
| Sophie Mukadam | Chief Operating Officer | 940,439 | 1981 |
| Claudia Kloth | Senior Vice President of Manufacturing | 0 | N/A |
Benitec Biopharma Inc. is an emerging biotechnology firm dedicated to advancing groundbreaking genetic medicines. The company specializes in DNA-directed RNA interference (RNAi) based treatments, which it develops to address severe and enduring human conditions. Its pipeline features BB-301, an adeno-associated virus (AAV) gene therapy aimed at treating oculopharyngeal muscular dystrophy, and BB-103, designed to combat chronic hepatitis B virus infection. Established in 1995, Benitec Biopharma's main operations are situated in Hayward, California.